Análisis Argos
PR
PRCara
Permian Resources Corporation · Energy
US$ 18.20
precio al 2026-07-04
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
49/100
LA RESPUESTA
El mercado le pide crezca 54.4% al año — más de lo que ha demostrado (5.1%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
✓Reparte dividendo sostenible (3.41%).
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
VALOR1/6FUTURO6/6PASADO2/6SALUD3/6DIVIDENDO4/6
El Iris de calidad
VALOR1/6FUTURO6/6PASADO2/6SALUD3/6DIVIDENDO4/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial aceptable
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos49de 100Cara
Ingresos▲1%
US$ 5.1 B
Margen operativo▼17%
29%
Flujo de caja libre▲93%
US$ 0.6 B
Deuda neta
US$ 3.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 13.0B
P/E13.9x
EV/EBITDA4.7x
FCF yield4.3%
ROIC8.5%
Margen operativo29%
Crecim. ingresos+1.3%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

gurufocus.com · 26 jun
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Rever
zacks.com · 5 jun
Permian Resources (PR) Up 0.4% Since Last Earnings Report: Can It Continue?
Permian Resources (PR) reported earnings 30 days ago. What's next for the stock?
gurufocus.com · 1 jun
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operat
zacks.com · 20 may
Permian Resources (PR) is a Top-Ranked Momentum Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
seekingalpha.com · 19 may
Permian Resources: Better Business, But Smaller Margin Of Safety
Permian Resources has fundamentally improved, with stronger production growth, cost control, and capital discipline supporting a continued Buy rating. PR's operational execution excels, with unit costs dropping from $725 to $685 per lateral foot, enhancing margins alongside production growth. Leverage declined to 0.8x and liquidity improved, while bolt-on acquisitions and disciplined balance sheet management strengthened PR's strategic positioning.
zacks.com · 18 may
Permian Resources (PR) is a Great Momentum Stock: Should You Buy?
Does Permian Resources (PR) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com · 14 may
Here's Why Permian Resources (PR) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
marketbeat.com · 14 may
Permian Resources Q1 Earnings Call Highlights
Permian Resources NYSE: PR reported what executives described as a record quarter for free cash flow and operational efficiency, while emphasizing that the company is preserving flexibility amid volatile commodity markets.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.